Westlake Therapeutics
Hangzhou, China · Founded 2019 · $27.6M raised
- Headquarters
- Hangzhou
- Founded
- 2019
- Business Model
- B2B
- Website
- westlaketpx.com
- Total Funding
- $27.6M
- Last Round
- $13.8M Series AJun 2022
- Rounds
- 4
About
Biotech developing engineered red blood cell therapeutics for cancer, immunological, and metabolic diseases via its REDx platform.
Summary
Westlake Therapeutics is a Biotech company based in Hangzhou, China, founded in 2019. It has raised $27.6M in total across 4 rounds, most recently a $13.8M Series A round in Jun 2022. Investors include Westlake University and Eight Roads Ventures.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2022
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Clinical-stage biotechnology company developing T-cell engager therapeutics for autoimmune and in...